Drug Database
OX

oxybutynin hydrochloride (Oablok / Neoxy Tape)

✓ Approved

Asahi Kasei · 小分子 · 小分子

什么是 oxybutynin hydrochloride?

oxybutynin hydrochloride 是一种小分子,由Asahi Kasei研发。该药已获批,用于治疗相关适应症,给药途径:Topical、Transdermal。

药物档案

商品名Oablok, Neoxy Tape
公司Asahi Kasei
药物类别小分子
给药途径Topical, Transdermal
状态Approved

治疗适应症

oxybutynin hydrochloride 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Renal and urinary disordersHypertonic bladder✓ Approved

相关研究文献

PubMedAdvanced healthcare materials2026-11-17

From Transdermal Delivery to Immune Reprogramming: Intelligent Biomaterials for Precision Psoriasis Therapy.

Jiang Xue X, Lu Yang Y, Hu Zhuang Z, Wen Peng P et al.

Psoriasis is a chronic immune-mediated inflammatory disease that causes dysregulation of keratinocyte proliferation, IL-23/IL-17-driven immune activation, oxidative stress and impaired barrier function. Biologics and targeted small molecules have improved clinical results, but systemic administration and lack of lesion specificity limit precise, long-term control of the disease. This paper revises the concept of psoriasis therapy from transdermal drug delivery to intelligent immune microenvironment reprogramming. Programmable biomaterial platforms that can actively recognize pathological signals and achieve spatiotemporal control of drug release, immune cell targeting, gene regulation and tissue remodelling have been introduced. Recently, there have been many developments in stimuli-responsive hydrogels, microneedle-based gene editing, biomimetic nanoplatforms, extracellular matrix-inspired scaffolds, and image-guided theranostic systems that link disease mechanisms, material design and therapeutic functions in a unified framework. We have further put forward the idea of cytokine blockade as a network-level immune recalibration, enhanced penetration and lesion-specific adaptive regulation, and image-guided precise intervention over empirical treatment. The three main translation problems are lesion heterogeneity, controllable immune modulation and large-scale manufacturing and long-term safety. This review provides a plan for developing intelligent, personalized biomaterial-based therapies for personalized psoriasis management.

PMID 43040914
阅读全文 →
PubMedBMC pharmacology & toxicology2026-11-17

Bioequivalence of two formulations of amitriptyline hydrochloride tablets in healthy Chinese subjects under fasting and fed conditions.

Zhang Jingjing J, Zhai You Y, Kai Jiejing J, Wu Minglan M et al.

The study evaluated the bioequivalence and tolerability of a generic amitriptyline hydrochloride tablet compared to the reference product in healthy Chinese subjects under both fasting and postprandial conditions to support its marketing authorization. A single-center, open-label, randomized, single-dose, two-period, two-sequence crossover study was conducted. Eligible subjects took a single 25 mg dose of the generic or reference product per cycle in random order. Plasma drug concentrations were detected by LC-MS/MS and the bioequivalence of the two formulations was assessed through key pharmacokinetic parameters (Cmax, AUC0-t, and AUC0-∞) of amitriptyline. Adverse events were continuously monitored throughout the trial. The 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of Cmax, AUC0-t, and AUC0-∞ between the two products fell within the 80-125% range under both fasting and postprandial conditions. Our study indicated that food intake increases systemic exposure to amitriptyline without affecting Tmax. Both formulations were well tolerated, with predominantly mild adverse events and no severe or fatal events. The generic amitriptyline hydrochloride tablets by Changzhou Siyao Pharmaceuticals Co., Ltd. were bioequivalent to the reference formulation by Sandoz Inc. with comparable tolerability. This study was registered at www.chinadrugtrials.org.cn under the registration number CTR20212242 (November 2, 2021).

PMID 43040400
阅读全文 →
PubMedBiomedical chromatography : BMC2026-11-17

Quality Evaluation of Bazhen Yimu Tablets Based on HPLC Fingerprints and QAMS Method Combined With Chemometrics.

Yang Ting T, Wang Sheng S, Deng Xiaohong X, Jiang Xun X et al.

Bazhen Yimu tablets is a commonly used Chinese patent medicine. It has the functions of replenishing qi and nourishing blood, regulating menstruation and relieving pain. In this study, an HPLC method was employed to develop fingerprints for 15 batches of Bazhen Yimu tablets, followed by similarity evaluation. Chemical pattern recognition analysis was performed on different batches using cluster analysis (CA), principal component analysis (PCA), and orthogonal partial least squares-discriminant analysis (OPLS-DA). Concurrently, a QAMS method was established using paeoniflorin as the internal reference substance to determine the relative correction factors between the internal reference and atractylenolide III, leonurine hydrochloride, benzoylpaeoniflorin, 1,2,3,4,6-pentagalloylglucose, glycyrrhizic acid, senkyunolide A, chlorogenic acid, ferulic acid, 3-butylidenephthalide, and Z-ligustilide. The contents of 11 components in Bazhen Yimu tablets were determined separately using both the external standard method (ESM) and the QAMS method to verify the reliability of the QAMS results. The HPLC fingerprint and QAMS method developed in this study demonstrate good reproducibility and operational simplicity, and can provide a reference for the quality control and comprehensive evaluation of Bazhen Yimu tablets.

PMID 43041115
阅读全文 →
PubMedJournal of forensic sciences2026-11-17

Screening of residual solvents in cocaine seizures by HS-SPME-GC-MS: Application to multi-class solvent profiling.

Góngora Juan J

A headspace solid-phase microextraction coupled to gas chromatography-mass spectrometry (HS-SPME-GC-MS) method was developed for the screening of 50 residual solvents (RS), including alcohols, ethers, esters, ketones, aliphatics, aromatics, and chlorinated solvents. Given the chemical diversity of the compounds, a diluent selection step was critically addressed to ensure analyte compatibility. Some key GC parameters were optimized using a one-variable-at-a-time (OVAT) approach, whereas HS-SPME extraction parameters (extraction time, temperature, desorption time) were optimized using a design of experiments (DoE) strategy. A semi-quantitative assessment using model solvent mixtures supported method optimization and characterization of the target compounds. Quantitative validation was performed for the most frequently encountered residual solvents, demonstrating good selectivity, coefficients of determination (R2 = 0.981-0.998), low detection limits (0.07-0.29 mg L-1), satisfactory recoveries (70.2%-117.4%), and acceptable intra- and inter-day precision (RSD <15%). The proposed approach shows adequate performance for screening volatile residues in complex drug matrices such as cocaine hydrochloride. However, because the extraction strategy is based on saturated aqueous NaCl and does not require organic solvents, it can potentially be extended to other drug matrices that are soluble in aqueous media. This characteristic makes the approach particularly suitable for routine forensic applications. A kinetic study further revealed compound-dependent profiles, with rapid initial sorption followed by stabilization (e.g., aliphatics and ethers), whereas aromatics and several ketones showed a more progressive increase, indicating that equilibrium was not generally reached under the evaluated HS-SPME conditions.

PMID 43040781
阅读全文 →
PubMedInternational journal of pharmaceutics2026-11-16

Transdermal delivery of cobimetinib via HPMC gel combining menthol and iontophoresis for locoregional melanoma treatment.

Jiang Changzhao C, Wang Zhixiong Z, Hu Jianling J, Wu Jialin J et al.

Orally administered cobimetinib (COBI), a selective MEK1/2 inhibitor is effective against melanoma but is associated with systemic adverse events. Herein, the HPMC-based gel combining menthol and iontophoresis was developed for locoregional transdermal delivery of COBI. Formulation was optimized via single-factor screening and an L9(33) orthogonal design. Optimized gels exhibited acceptable rheological properties and physical stability under stress conditions. In vitro permeation using excised rat abdominal skin revealed that 5% (w/w) menthol significantly enhanced COBI permeation, while iontophoresis was optimized at 3 h with 0.45% (w/w) NaCl. Based on the in vitro optimization, 0.8% (w/w) COBI loading was selected as the medium-dose candidate for subsequent in vivo efficacy evaluation (with 0.4% and 1.2% evaluated as low and high doses, respectively). In B16F10 cells, COBI combined with mild direct current showed greater inhibition of cell viability than either treatment alone. In tumor-bearing C57BL/6 mice, the optimized gelplus iontophoresis achieved achieved a tumor-weight inhibition rate of 98.2%, with histological findings suggesting increased tumor necrosis and reduced proliferation. At an equivalent dose, passive transdermal administration produced lower systemic exposure than oral dosing, whereas iontophoresis achieved comparable systemic exposure to passive delivery at half the nominal dose. In a separate mouse study, selected transdermal regimens exhibited higher tumor-to-plasma concentration ratios than oral administration at a single sampling time point. Collectively, this study demonstrates that the HPMC gel combining menthol and iontophoresis enables effective local tumor suppression.

PMID 43039121
阅读全文 →
PubMedACS biomaterials science & engineering2026-11-16

Barbed Dissolving Poly-γ-Glutamic Acid Microneedles for Reduced-Frequency Transdermal Levothyroxine Delivery in Hypothyroidism.

He Yan Y, Wang Panxia P, Wen Jiangyan J, Li Ying Y et al.

Hypothyroidism often requires lifelong thyroid hormone replacement, but oral levothyroxine (LT4) treatment depends on daily administration and gastrointestinal absorption. Here, we developed an LT4-loaded barbed dissolving microneedle patch based on poly-γ-glutamic acid (γ-PGA) (LT4@MN) for reduced-frequency transdermal delivery. LT4 was incorporated into the needle region, while the γ-PGA backing was prepared without the drug. The microneedles exhibited well-defined morphology, sufficient mechanical strength, moisture-responsive dissolution behavior, effective skin penetration to a depth of approximately 700 μm, and favorable cytocompatibility. In a total thyroidectomy-induced hypothyroid rat model, LT4@MN administered once every 6 days increased serum total thyroxine (TT4) from the hypothyroid baseline and maintained elevated TT4 levels across three consecutive treatment cycles. However, serum thyroid-stimulating hormone (TSH) did not show a clear sustained decrease during treatment. Repeated application caused no obvious local tissue damage or histopathological abnormalities in major organs. These findings support the feasibility of reduced-frequency transdermal LT4 delivery using barbed dissolving γ-PGA microneedles and highlight their potential as a minimally invasive alternative to daily oral administration.

PMID 43037648
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多oxybutynin hydrochloride